BENEFIT OF ADHERENCE DEPENDS ON AGE AND FRACTURE TYPE – (5-11-09)



Benefit of Adherence With Bisphosphonates Depends on Age and Fracture Type

I’ve always felt that anti-resorptive therapy is the complete wrong way to approach improving bone health. A few things with this study. First, take 10 minutes or so to read through the rather extensive list of conflict of interests!! Next, look at how low the adherence is. Lastly, even with high adherence to medication use, the number of patients that need to be treated to prevent 1 hip fracture is 107.

This number would need to be much, much higher at lower rates of adherence found across the board in the people taking this drug. This is a very high number, suggesting that this class of drugs should not even be used, which is of course contrary to the huge number of scripts written for this class. I’ve always said that if the general public truly understood how useless and dangerous many of these drugs were there would be a paltry market for them.

Read entire article here

James Bogash

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.







Email:



Posted on
Categories: Drug Research, Osteoporosis Cures and Bone Health
Disclosure of Material Connection: Some of the links in the post above are “affiliate links.” This means if you click on the link and purchase the item, I will receive an affiliate commission. Regardless, I only recommend products or services I use personally and believe will add value to my readers. I am disclosing this in accordance with the Federal Trade Commission’s 16 CFR, Part 255: “Guides Concerning the Use of Endorsements and Testimonials in Advertising.”